Pharmaton
Pharmaton, licence 80029424: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Vitality
- Licence holder
- Opella Canada Inc.
- NPN or DIN-HM
- 80029424
- Status
- Active licence
- Licence date
- 7 February 2012
- Revision date
- 12 April 2021
- Form
- Capsule, enrobage gélatine
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sélénium Source : Sélénite de sodium | 0.055 mg | Not calculated |
| Zinc Source : Sulfate de zinc monohydraté | 1.5 mg | Not calculated |
| Cholécalciférol Source : Cholécalciférol Potency : 200.0 UI | 5.0 mcg | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 1.708 mg | Not calculated |
| Lécithine Source : Lecithin | 100.0 mg | Not calculated |
| 3-Pyridinecarboxamide Source : Niacinamide | 16.13 mg | Not calculated |
| Fer Source : Sulfate ferreux | 10.5 mg | Not calculated |
| Thiamine Source : Mononitrate de thiamine | 1.36 mg | Not calculated |
| Vitamine B12 Source : Vitamine B12 | 2.5 mcg | Not calculated |
Non-medicinal ingredients
Oxyde de fer (Fe2O3), Oxyde de fer noir, Ethylvanilline, Gélatine, Ester d'acide citrique et d'acide gras de glycérol, Huile de graine de canola, Triglycéride caprylique/caprique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Supports cognitive function and/or reduce mental fatigue. Helps to enhance physical capacity/performance. Supportive therapy for the promotion of healthy glucose levels. A factor in the maintenance of good health. Helps to maintain eyesight, skin, membranes and immune function. Helps in the development and maintenance of night vision. Helps in the development and maintenance of bones, cartilage, teeth and gums. Helps in wound healing. Helps in the absorption and use of calcium and phosphorus. Contains antioxidants for the maintenance of good health. Helps the body to metabolize carbohydrates, fats and proteins. Helps normal growth and development. Helps in (connective) tissue formation. Helps to produce and repair connective tissue. Helps to form red blood cells and helps in their proper function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not take with blood thinners. Do not take with Vitamin A derivatives called "retinoids" (prescribed to treat acne). Do not take with Vitamin D (for treatment). PHARMATON CAPSULES are contraindicated in patients with disturbances of calcium metabolism (e.g., hypercalaemia and hypercalciuria), with hypervitaminosis, with renal insufficiency, during therapy with retinoids (e.g., against acne) or vitamin D, and in patients with known hypersensitivity to any ingredients of the compound. This product is contraindicated in patients with a history of allergy to soya or peanuts. In case of rare hereditary conditions that may be incompatible with an excipient of the product, the use of the product is contraindicated.
Source
Official Health Canada record, licence 80029424
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Has the product changed? Photograph the packaging.